Related Experiment Videos
Mutation spectrum of the p53 gene in bone and soft tissue sarcomas
J Toguchida1, T Yamaguchi, B Ritchie
1Howe Laboratory of Ophthalmology, Massachusetts Eye and Ear Infirmary, Boston 02114.
Abstract:
We present here an analysis of the spectrum of mutations of the p53 gene seen in 127 bone and soft tissue sarcomas of various histological classifications. Gross rearrangements were analyzed by Southern blotting using a complementary DNA probe from the p53 gene, and subtle alterations in the entire coding sequence (exons 2 through 11) were identified by a combination of single-strand conformation polymorphism analysis and direct genomic sequencing. A total of 42 somatic alterations of the p53 gene were found, of which 21 were gross rearrangements and 21 were subtle alterations. These included 17 cases of a single base substitution, 3 small deletions, and one single base insertion. In contrast to reported findings for other types of cancer, we found that mutations of the p53 gene in sarcomas are quite heterogeneous both in their distribution throughout the gene and in the type of genetic alterations that result. All 13 missense mutations we found occurred at highly conserved residues, whereas 8 nonsense mutations occurred at sites that spanned the gene from codons 46 to 316. Surprisingly, approximately one-half of the osteosarcomas with allelic deletions on 17p did not have detectable alterations in the coding sequence of the p53 gene.
Insights
p53 gene mutations in bone and soft tissue sarcomas are diverse, unlike other cancers. Researchers found 42 alterations, including rearrangements and subtle changes, highlighting sarcoma
Area of Science:
- Oncology
- Molecular Biology
- Genetics
Background:
- The p53 gene is a critical tumor suppressor involved in various cancers.
- Understanding p53 gene mutations in sarcomas is essential for diagnosis and treatment.
- Previous studies have characterized p53 mutations in other cancer types.
Purpose of the Study:
- To analyze the spectrum of p53 gene mutations in a cohort of 127 bone and soft tissue sarcomas.
- To investigate the types and distribution of genetic alterations in the p53 gene within sarcomas.
- To compare sarcoma p53 mutation patterns with those observed in other malignancies.
Main Methods:
- Southern blotting was used to detect gross rearrangements of the p53 gene.
- Single-strand conformation polymorphism analysis and direct genomic sequencing identified subtle alterations in exons 2-11.
- Analysis included 127 bone and soft tissue sarcomas of various histological types.
Main Results:
- A total of 42 somatic alterations in the p53 gene were identified (21 gross rearrangements, 21 subtle alterations).
- Subtle alterations included 17 base substitutions, 3 small deletions, and 1 insertion.
- p53 mutations in sarcomas were found to be heterogeneous in distribution and type, differing from other cancers.
Conclusions:
- p53 gene mutations in sarcomas exhibit significant heterogeneity, distinct from patterns seen in other cancers.
- Missense mutations occurred at conserved residues, while nonsense mutations were more broadly distributed.
- A notable finding was that about half of osteosarcomas with 17p allelic deletions lacked detectable p53 coding sequence alterations.